Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07117955 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Platelet-Rich Plasma for Peyronie's Disease

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date changed from estimate of Sep 20, 2025 to Oct 21, 2025
    • Eligibility criteria expanded, about 13 words
    • Secondary endpoints: details revised at 7 of 7 entries
    • Study description revised
  2. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    • Study title shortened, about 8 words
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this clinical trial is to evaluate the effects of Platelet-Rich Plasma (PRP) intralesional injections in men affected by Peyronie's disease (PD) in the fibrotic phase.
Trial Details
NCT Number NCT07117955
Lead Sponsor Herlev Hospital
Conditions
(from sponsor)		 Peyronies Disease
Related terms Penile Induration
Enrollment 84 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov